IP Library Granted Patent US 12708701
Granted Patent B2
US 12708701 · App. 18/103,102 · Granted Aug 18, 2026

Specialty fibrin product

Inventors: Mark H. Widick (Boca Raton, FL); Abraham Lavi (Delray Beach, FL)
Assignee: Fibrin, LLC
A61L31/046A61L31/047A61L31/146A61L31/148C08J9/0066C08J9/30C08L89/00A61L2430/40C08J2207/10C08J2389/00C08L2201/06C08L2203/02C08L2203/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12708701
App. No.
18/103,102
Granted
Aug 18, 2026
Kind
B2
Abstract

The present invention is a specially prepared fibrin foam, and a method of (and equipment for) making it, which is flexible, contains either open cells, closed cells or both, and having individual cell diameters between 0.001 and 2 mm. Typical ratios of reactants, to give the desired foam characteristics, include 50 cc (45-55 cc) of whole blood (prior to separation to the plasma component) with the subsequent addition thereto of 2 ml (1.5-2.5 ml) 3% hydrogen peroxide, 5000 units (4500-5500 units) thrombin and 1 gm (0.9-1.1 g) calcium chloride in 3 cc (2-4 cc) water. The present invention also includes specialty vessels and constructs, namely, automated, or semi-automated inner containers for the non-blood reactants, and a custom outer separation vessel having a punted based with an annular base lip as well as an upper tube shape tapering inward towards its top annular opening.

Claims (13)

1 . A method of producing a medical fibrin foam, the method comprising:

collecting a whole blood sample having a volume between 45 and 55 cc from a subject;

separating a plasma fraction from the whole blood sample by centrifuging the whole blood sample;

forming a reaction mixture by admixing into the plasma fraction;

a volume of water between 2 and 4 cc;

a volume of 3% hydrogen peroxide between 1.5 and 2.5 ml;

an amount of thrombin between 4,500 and 5,500 units;

an amount of calcium chloride between 0.9 and 1.1 g;

forming a quantity of fibrin foam from the reaction mixture;

separating the quantity of fibrin foam from unreacted constituents of the reaction mixture; and

obtaining the medical fibrin foam by curing the quantity of fibrin foam.

2 . The method according to claim 1 , wherein the curing has a duration between 5 and 60 minutes.

3 . The method according to claim 1 , wherein the volume of the collected whole blood sample is 55 cc, the volume of admixed 3% hydrogen peroxide is 2 ml, the amount of the admixed thrombin is 5,000 units, and the amount of the admixed calcium chloride is 1 g.